
Agios Pharmaceuticals Sees Shift in Fund Positioning Russell 1000
Highlights,Rhumbline Advisers reduces share count in NASDAQ:AGIO during Q1,Several institutional firms made changes to their AGIO share allocations,New coverage and ratings issued by firms following AGIO's performance,Agios Pharmaceuticals Inc. (NASDAQ:AG...
- June 16, 2025 07:04 AM PDT
- Team Kalkine Media